Supervised learning of few dirty bosons with variable particle number

by Pere Mujal, Àlex Martínez Miguel, Artur Polls, Bruno Juliá-Díaz, Sebastiano Pilati
Published 2021-03-01

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).

by Susana Cedrés, Santiago Ponce-Aix, Jon Zugazagoitia, Irene Sansano, Ana Enguita, Alejandro Navarro-Mendivil, Alex Martinez-Marti, Pablo Martinez, Enriqueta Felip
Published 2015-01-01

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation

by Enrique J. Arenas, Alex Martínez-Sabadell, Irene Rius Ruiz, Macarena Román Alonso, Marta Escorihuela, Antonio Luque, Carlos Alberto Fajardo, Alena Gros, Christian Klein, Joaquín Arribas
Published 2021-02-01

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

by Ana Callejo, Joan Frigola, Patricia Iranzo, Caterina Carbonell, Nely Diaz, David Marmolejo, Juan David Assaf, Susana Cedrés, Alex Martinez-Marti, Alejandro Navarro, Nuria Pardo, Ramon Amat, Enriqueta Felip
Published 2021-06-01

Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patients.

by Pablo Martinez, Javier Hernández-Losa, Ma Ángeles Montero, Susana Cedrés, Josep Castellví, Alex Martinez-Marti, Natalia Tallada, Nuria Murtra-Garrell, Alejandro Navarro-Mendivill, Victor Rodriguez-Freixinos, Mercedes Canela, Santiago Ramon y Cajal, Enriqueta Felip
Published 2013-01-01

Proceso participativo de producir un mapa integrado de Centroamérica y sur de México

by Marcela Norori, Carren Williams, Elam Torres, Leonardo Salazar, Eduardo Sáncho, Emma Flores, Blanca Isabel Gómez, Francisco Benítez, Regina Menendez, Milton Núñez, Alex Martínez, Jean Parcher, Roberto Lugo, Eufracio Zavala, Noel Ramírez, José Pérez, Carlos Morales, Elizabeth Samuels, Rogelio Mondragón
Published 2019-10-01

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

by Joan Frigola, Alejandro Navarro, Caterina Carbonell, Ana Callejo, Patricia Iranzo, Susana Cedrés, Alex Martinez‐Marti, Nuria Pardo, Nadia Saoudi‐Gonzalez, Debora Martinez, Jose Jimenez, Irene Sansano, Francesco M. Mancuso, Paolo Nuciforo, Luis M. Montuenga, Montse Sánchez‐Cespedes, Aleix Prat, Ana Vivancos, Enriqueta Felip, Ramon Amat
Published 2021-04-01

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

by João M. Fernandes Neto, Ernest Nadal, Evert Bosdriesz, Salo N. Ooft, Lourdes Farre, Chelsea McLean, Sjoerd Klarenbeek, Anouk Jurgens, Hannes Hagen, Liqin Wang, Enriqueta Felip, Alex Martinez-Marti, August Vidal, Emile Voest, Lodewyk F. A. Wessels, Olaf van Tellingen, Alberto Villanueva, René Bernards
Published 2020-06-01

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

by Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, Ernest Nadal, Amelia Insa, María del Rosario García‐Campelo, Gerardo Huidobro, Manuel Dómine, Margarita Majem, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Marta Casarrubios, Belén Sierra‐Rodero, Carlos Tarín, Aránzazu García‐Grande, Cara Haymaker, Ignacio I. Wistuba, Atocha Romero, Fernando Franco, Mariano Provencio
Published 2021-07-01